Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Taxane”

437 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 437 results

Testing effectiveness (Phase 2)UnknownNCT01088893
What this trial is testing

Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

Who this might be right for
Breast Neoplasms
Organisation for Oncology and Translational Research 50
Testing effectiveness (Phase 2)Study completedNCT00291837
What this trial is testing

CT-2106 for the Second Line Treatment of Ovarian Cancer

Who this might be right for
Ovarian Cancer
CTI BioPharma 40
Large-scale testing (Phase 3)Looking for participantsNCT05862064
What this trial is testing

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 606
Testing effectiveness (Phase 2)Study completedNCT02268695
What this trial is testing

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 541
Not applicableStudy completedNCT03568526
What this trial is testing

Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer

Who this might be right for
Peripheral NeuropathyStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
Ohio State University Comprehensive Cancer Center 36
Large-scale testing (Phase 3)Study completedNCT00082433
What this trial is testing

Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Who this might be right for
CancerBreast Cancer
R-Pharm 1,221
Large-scale testing (Phase 3)Study completedNCT00512993
What this trial is testing

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 654
Not applicableStudy completedNCT03983538
What this trial is testing

Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
New Mexico Cancer Research Alliance 10
Testing effectiveness (Phase 2)Study completedNCT00182767
What this trial is testing

Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer

Who this might be right for
Fallopian Tube CancerFemale Reproductive CancerRecurrent Breast Cancer+4 more
National Cancer Institute (NCI) 45
Large-scale testing (Phase 3)Ended earlyNCT01641939
What this trial is testing

Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 415
Not applicableUnknownNCT04651907
What this trial is testing

Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Who this might be right for
Chemotherapy-Induced Peripheral Neuropathy (CIPN)
China Medical University Hospital 94
Large-scale testing (Phase 3)Looking for participantsNCT05642611
What this trial is testing

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Who this might be right for
Malignant Solid Neoplasm
SWOG Cancer Research Network 777
Testing effectiveness (Phase 2)Ended earlyNCT00653328
What this trial is testing

Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Vanderbilt-Ingram Cancer Center 15
Early research (Phase 1)Study completedNCT02038010
What this trial is testing

BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IIIA Breast Cancer+3 more
Northwestern University 17
Not applicableStudy completedNCT03139435
What this trial is testing

Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer

Who this might be right for
Peripheral NeuropathyStage 0 Breast CancerStage I Breast Cancer+10 more
Wake Forest University Health Sciences 20
Large-scale testing (Phase 3)Looking for participantsNCT05009082
What this trial is testing

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
AGO Study Group 970
Not applicableWithdrawnNCT00551265
What this trial is testing

Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy

Who this might be right for
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Ovarian Carcinoma+2 more
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT01495884
What this trial is testing

The Myocet/Lapatinib Study. ICORG 10-03, V5

Who this might be right for
Her2 Positive Metastatic Breast Cancer
Cancer Trials Ireland 11
Large-scale testing (Phase 3)Study completedNCT00277043
What this trial is testing

A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes

Who this might be right for
SupportiveIll-defined Sites
New Mexico Cancer Research Alliance 200
Early research (Phase 1)Ended earlyNCT01290380
What this trial is testing

Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Solid Tumor Malignancies
Novartis Pharmaceuticals 54
Load More Results